Expands and strengthens neurology portfolio with three marketed CNS products and late-stage pipelineDiversifies revenue and operating cash flow base with […]
-Enrollment ongoing in clinical trials of CTX001™ for patients with severe hemoglobinopathies--Enrollment ongoing in clinical trial of CTX110™, targeting CD19+ […]